Degron Therapeutics
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
3210 Merryfield Row, San Diego, Californ...Website
www.degrontx.comRevenue
$10.8 MillionIndustry
ZI Rank: 1
About Degron Therapeutics
Degron Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Degron Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Degron Therapeutics recently announced quarterly report
Funding: Get notified immidiatlly once Degron Therapeutics has new funding data
Check if Degron Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Degron Therapeutics
Click to see if Degron Therapeutics had a recent Job posting/layoffs
Product Launch: Get notified when Degron Therapeutics launches new products
Check out if Degron Therapeutics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Degron Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Degron Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Degron Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Degron Therapeutics.
Degron Therapeutics financials insights
Gather financial insights about Degron Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$22M
Other Financing Round
$40M
Degron Therapeutics Tech Stack
A closer look at the technologies used by Degron Therapeutics
Most Recent Scoops
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Degron Therapeutics
Dago Bio aims to become the world's leading research and development company for innovative protein degradation drugs-molecular glue-based small molecule new drugs. The Dago team, composed of world-class managers and scientific leaders with international vision and rich industry experience, will focus on the discovery and verification of new, espec... Read More
